Stelara was approved in 2016 to treat Crohn’s disease and in 2019 for ulcerative colitis. It was the first biologic medicine that targets interleukin (IL)-12 and IL-23.

Tel: 0208 949 6209 www.cicra.org Dedicated to creating a wider understanding of Crohn's Disease and Ulcerative Colitis particularly as it affects children and young adults.

Laboratory tests for C-reactive protein and fecal calprotectin can reveal signs of inflammation, a key component of both Crohn's and ulcerative colitis. But these tests are non-specific, Winter said.

Session ID: 2025-07-30:443a372dce56e5c7566e53b7 Player Element ID: Vf5db4b3f_067a_4ffa_a069_e3a39ca9b07f_6371178589112 ...

BOSTON, MA / ACCESSWIRE / October 3, 2024 /PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced a partnership with the Crohn's & Colitis ...

If you have ulcerative colitis, a colonoscopy is an important tool for diagnosing and monitoring your condition. It's also the best way to screen for colon cancer, which is slightly more common in ...

You can have Crohn's colitis only or more than one type of Crohn's at the same time. Despite having a similar name, this condition is not the same as ulcerative colitis.

December 1-7 is Crohn's and Colitis Awareness Week - a time to shine a light on the two main forms of inflammatory bowel disease (IBD).

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved guselkumab (Tremfya) for the treatment of Crohn’s disease and ulcerative colitis (UC). Already used for plaque psoriasis and ...

We found that prior to diagnosis, this mixture of chemicals was linked with increased risk of both ulcerative colitis and Crohn's disease at 6-10 years before diagnosis, but not at time points ...